Zydus Wellness discloses promoter group share transmission of 27,250 units

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

Zydus Wellness transmitted 27,250 equity shares to promoter group member Prashant Babubhai Patel. Shares were transferred from the estate of Late Jasodaben Babubhai Patel via off-market transmission. The transaction occurred on August 19, 2026, with no monetary consideration involved. Disclosure filed under SEBI PIT Regulations 2015 on August 24, 2026.

powered bylight_fuzz_icon
49134426

*this image is generated using AI for illustrative purposes only.

Zydus Wellness disclosed the transmission of 27,250 equity shares to Prashant Babubhai Patel, a member of the promoter group. The transfer occurred on August 19, 2026, following the demise of Late Jasodaben Babubhai Patel.

The company filed the disclosure on August 24, 2026, with the Bombay Stock Exchange and National Stock Exchange of India Limited. The filing adheres to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Transaction Details

Prashant Babubhai Patel acquired the shares through an off-market transmission process. The transaction did not involve any monetary consideration, as indicated by the nil value recorded in the Form B filing. The acquisition increased his holding from zero to 27,250 equity shares.

Metric Details
Acquirer Prashant Babubhai Patel
Transferor Late Jasodaben Babubhai Patel
Shares Transmitted 27,250 equity shares
Date of Acquisition August 19, 2026
Mode Off Market Transmission
Consideration Nil

The intimation was received by the company on August 21, 2026. As per the filing, the shareholding percentage remains at 0.00% for both pre- and post-acquisition periods, indicating the stake is immaterial relative to the total issued capital.

Historical Stock Returns for Zydus Wellness

1 Day5 Days1 Month6 Months1 Year5 Years
+4.14%+0.16%-13.70%+25.69%+27.60%+15.31%

Will Prashant Babubhai Patel's acquisition of these shares trigger any further insider trading disclosures or changes in the promoter group's voting rights structure?

How might this succession event within the promoter family impact investor confidence in Zydus Wellness' corporate governance and long-term stability?

Are there any pending estate settlement processes or tax implications associated with this transmission that could affect the company's administrative workload or public perception?

Zydus Wellness net sales surge 67% to ₹14,299 mn in Q1FY27

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

Zydus Wellness Ltd reported consolidated net sales of ₹14,299 million in Q1FY27, a 66.7% increase YoY, driven by international expansion and premium brand performance. While EBITDA rose 55.3% to ₹2,417 million, PAT declined 7.0% to ₹1,189 million due to amortization and interest costs from the Comfort Click acquisition. Adjusted net profit grew 26.5% to ₹1,679 million. Key brands like Sugar Free and RiteBite Max Protein showed strong growth, while seasonal brands faced headwinds from unseasonal rainfall. The company also highlighted a transition to lower-cost Euro-denominated debt and a projected effective tax rate of 25% excluding regulatory disallowances.

powered bylight_fuzz_icon
47373388

*this image is generated using AI for illustrative purposes only.

Zydus Wellness reported a 66.7% year-on-year increase in consolidated net sales to ₹14,299 million for the quarter ended June 30, 2026, driven by strong international expansion and premiumization trends in its core nutrition and personal care brands. While EBITDA grew 55.3% to ₹2,417 million, profit after tax (PAT) declined 7.0% to ₹1,189 million due to acquisition-related amortization and interest costs. Adjusted net profit, however, rose 26.5% to ₹1,679 million, signaling robust underlying operational leverage despite headwinds from unseasonal rainfall impacting seasonal brands.

The filing, submitted to BSE and NSE on August 4, 2026, details the unaudited financial results for Q1FY27. Revenue from operations stood at ₹14,370 million, up from ₹8,609 million in the corresponding period of the previous year. Gross contribution improved by 99.5% to ₹9,436 million, with gross margin expanding to 65.5% from 54.8%. The Board of Directors reviewed the performance, noting that international business delivered high double-digit growth despite geopolitical disruptions.

Financial Performance

The company’s financial metrics for Q1FY27 reflect significant top-line expansion, although net profitability was impacted by non-operating expenses related to recent acquisitions, specifically Comfort Click.

Metric Q1FY27 (₹ Mn) Q1FY26 (₹ Mn) YoY Growth
Net Sales 14,299 8,577 66.7%
EBITDA 2,417 1,556 55.3%
EBITDA Margin 16.8% 18.1% -130 bps
PAT 1,189 1,279 -7.0%
Adjusted Net Profit 1,679 1,327 26.5%

Profit after tax (PAT) declined 7.0% to ₹1,189 million due to interest expenses on Euro-denominated loans for the Comfort Click acquisition and amortization of acquired brands. However, adjusted net profit, which adds back amortization, rose 26.5% to ₹1,679 million. Adjusted EPS increased to ₹5.28 from ₹4.17. CFO Umesh Parikh noted that the transition from GBP to Euro loans resulted in reduced interest costs, with the effective finance cost expected to remain stable unless benchmark rates fluctuate significantly.

Brand and Segment Highlights

Sugar Free strengthened its leadership in the sugar substitute category with a market share of 96.1%. Core brands Sugar Free D'Lite and I'm Lite delivered double-digit growth. Glucon-D maintained its leadership position with a 59.1% market share, though growth was flattish due to weak demand in the East region caused by frequent showers. RiteBite Max Protein continued to lead the nutrition protein bars, cookies, and chips category, growing at more than double its historical rate through brand building, distribution expansion, and portfolio enhancements like millet-based wafer bars.

In personal care, Everyuth led the scrubs and peel-off categories with market shares of 49.4% and 75.5% respectively, improving its ranking to fourth in facial cleansing with an 8.2% share. Nycil maintained leadership in the prickly heat category with a 32.9% market share but faced challenges due to unseasonal rainfall in key North and East markets. Cuticolor performance was driven by strong consumer demand across organised retail channels.

Nutralite delivered double-digit growth, maintaining its leadership position in the fat spread category. Complan continued its growth momentum despite nutritional drink category degrowth, maintaining its fourth rank. The company launched Complan Power Play milk shake and VieMax Diabetes Care, a low glycaemic index nutrition solution.

Global Expansion and Tax Outlook

Under the Comfort Click portfolio, WeightWorld expanded its direct-to-consumer presence in the USA through entry into the Walmart Marketplace. In the UAE, WeightWorld and Maxmedix were launched on the Noon e-commerce platform. Domestically, domestic business grew 4.6% seasonally adjusted, while international revenues surged 24.8%. The Food and Nutrition segment led growth with a 34.5% year-on-year increase.

Regarding tax implications, CFO Umesh Parikh stated that the current effective tax rate is close to 27% due to disallowances under the UK thin cap rule. Excluding these items, the rate would be approximately 25%. For FY27, the cash component of the tax is expected to be between 12% and 15%, with the full 25% rate payable in cash from FY28 onwards.

What the Numbers Show

The divergence between declining PAT and rising EBITDA highlights the impact of acquisition-related costs. While core operations generated stronger cash flows, non-operating expenses—specifically interest on foreign debt and brand amortization—compressed net profitability. This suggests that as amortization stabilizes and debt structures optimize, net margins could recover toward historical levels, assuming top-line momentum continues. The shift towards digital-first consumer engagement and premium offerings appears to be successfully driving value-led growth even in degrowing categories.

Historical Stock Returns for Zydus Wellness

1 Day5 Days1 Month6 Months1 Year5 Years
+4.14%+0.16%-13.70%+25.69%+27.60%+15.31%

How will the transition to full cash tax payments of 25% starting FY28 impact Zydus Wellness' free cash flow and dividend payout ratios?

What specific strategies is Zydus Wellness employing to mitigate the demand headwinds in East India caused by unseasonal rainfall for seasonal brands like Glucon-D and Nycil?

Given the 130 bps compression in EBITDA margins, what operational efficiencies or pricing power mechanisms are in place to restore margin expansion in subsequent quarters?

More News on Zydus Wellness

1 Year Returns:+27.60%